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RESEARCH ARTICLE
Carcinoma Cells Misuse the Host Tissue
Damage Response to Invade the Brain
Han-Ning Chuang,1 Denise van Rossum,2 Dirk Sieger,3 Laila Siam,4 Florian Klemm,1
Annalen Bleckmann,1,5 Michaela Bayerlova,5 Katja Farhat,6 J€org Scheffel,2
Matthias Schulz,1 Faramarz Dehghani,7 Christine Stadelmann,2 Uwe-Karsten Hanisch,2
Claudia Binder,1 and Tobias Pukrop1
The metastatic colonization of the brain by carcinoma cells is still barely understood, in particular when considering interac-
tions with the host tissue. The colonization comes with a substantial destruction of the surrounding host tissue. This leads to
activation of damage responses by resident innate immune cells to protect, repair, and organize the wound healing, but may
distract from tumoricidal actions. We recently demonstrated that microglia, innate immune cells of the CNS, assist carcinoma
cell invasion. Here we report that this is a fatal side effect of a physiological damage response of the brain tissue. In a brain
slice coculture model, contact with both benign and malignant epithelial cells induced a response by microglia and astrocytes
comparable to that seen at the interface of human cerebral metastases. While the glial damage response intended to protect
the brain from intrusion of benign epithelial cells by inducing apoptosis, it proved ineffective against various malignant cell
types. They did not undergo apoptosis and actually exploited the local tissue reaction to invade instead. Gene expression
and functional analyses revealed that the C-X-C chemokine receptor type 4 (CXCR4) and WNT signaling were involved in this
process. Furthermore, CXCR4-regulated microglia were recruited to sites of brain injury in a zebrafish model and CXCR4 was
expressed in human stroke patients, suggesting a conserved role in damage responses to various types of brain injuries. To-
gether, our findings point to a detrimental misuse of the glial damage response program by carcinoma cells resistant to glia-
induced apoptosis.
GLIA 2013;61:1331–1346
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Introduction
Brain metastasis represents a severe clinical problem. Inparticular, carcinomas of the lung and breast metastasize
very frequently to the brain with tremendous impact on over-
all survival rate (Eichler et al., 2011). We recently demon-
strated that there is an overall survival rate of only 7 months
after neurosurgical resection for lung adenocarcinoma patients
(Bleckmann et al., 2013). In advanced breast cancer, 30% of
the patients develop brain metastasis. Interestingly, cerebral
metastasized breast cancer patients without neurological
symptoms have the same unfavorable prognosis as patients
with symptomatic brain metastasis. More importantly, these
patients have a worse prognosis in comparison to patients
with metastases at other sites, i.e., bone, liver, or lung
(Miller et al., 2003). This difference may result from the spe-
cial characteristics of the brain tissue and its unique microen-
vironment (Eichler et al., 2011; Fidler, 2011; Steeg et al.,
2011).
Interactions between malignant cells and the microenvir-
onment play a pivotal role in the first steps of metastasis. In
particular, in the primary tumor tumor-associated macro-
phages (TAM) can support cancer cell proliferation,
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migration, invasion, and intravasation as well as participate in
matrix remodeling and angiogenesis (Allavena et al., 2008;
Balkwill et al., 2005; Mantovani et al., 2008). These tumor-
promoting features in the primary are reflected in the clinical
outcome (Bingle et al., 2002). Interestingly, the typical target
organs of metastasis possess tissue-specific resident macro-
phages, such as Kupffer cells in the liver, alveolar macro-
phages in the lung, or microglia in the central nervous system
(CNS).
Microglia are important in the maintenance and protec-
tion of CNS homeostasis and functionality (Hanisch and Ket-
tenmann, 2007). They constitute the first line of defense and
exert effector functions on various infections and other kinds of
brain damage (e.g. stroke and brain injuries). Interestingly,
microglia express a range of pattern recognition receptors
(PRRs), including Toll-like receptors (TLRs), which allow the
detection of both infection as well as damage signals (Ketten-
mann et al., 2011). While pathogen-associated molecular pat-
terns (PAMPs) refer to an assortment of evolutionary conserved
structural motifs in glyco- and lipopeptides, glycolipids, DNA
and RNA of bacteria, viruses, fungi, or protozoa (Kawai and
Akira, 2010; Takeuchi and Akira, 2010), danger-associated mo-
lecular patterns (DAMPs) comprise a collection of disparate
molecules of endogenous origin. Under normal conditions they
have diverse functions, but acquire a danger signal upon some
nonphysiological release and=or structural modification
(Rubartelli and Lotze, 2007). They can drive a tissue response
also in the absence of infection agents, i.e. best described as
sterile inflammation (Chen and Nunez, 2010). DAMPs may
prepare, support, or modify reactions to PAMPs and install
programs for wound healing and repair. However, in certain
pathological settings, they do participate in destructive proc-
esses and even self-propelling cycles (Lehnardt et al., 2008;
Stewart et al., 2010). Their PRR=TLR equipment renders
microglia potentially sensitive to a plethora of DAMPs, includ-
ing those of cellular (heat shock proteins, high-mobility group
protein B1, and S100 calcium binding protein A8/A9), plasma,
or extracellular matrix (ECM) origin (fibrinogen, fibronectin,
tenascin, and versican). Furthermore, microglia are not simply
derivatives from monocytic cells of the bone marrow. They de-
velop from yolk sac progenitors, maintain themselves as a stable
population by self-renewal independently of the hematopoiesis
and possess the capacity to proliferate on demand (Ginhoux
et al., 2010; Kierdorf et al., 2013; Schulz et al., 2012). For
example, infections or injuries lead to an activation and prolif-
eration of microglia. Most importantly, activation of microglia
primarily serves in CNS protection but can occasionally con-
tribute to destructive processes and thereby aggravate clinical
symptoms upon acute insults or in chronic (neurodegenerative)
diseases (Hanisch and Kettenmann, 2007; Kettenmann et al.,
2011; Prinz et al., 2011).
However, in contrast to the role of bone marrow-
derived TAM in the primary tumor, the functions of these
tissue-specific macrophage-like cells during metastatic coloni-
zation and the subsequent tissue damage of the respective
organs have barely been investigated, in the case of microglia
they have been almost ignored (Gjoen et al., 1989; Heuff
et al., 1995; Steeg et al., 2011). Nevertheless, there are few
histological descriptions clearly demonstrating microglia-carci-
noma cell interactions. In particular, they revealed that micro-
glia infiltrate into the tumor mass, accumulate in the
surrounding gliosis zone, and create contacts with the carci-
noma cells directly after successful extravasation (Fitzgerald
et al., 2008; Lorger and Felding-Habermann, 2010; Zhang
and Olsson, 1997). These observations not only suggest a
role of microglia during brain metastasis but also reveal that
they interact directly after carcinoma cell extravasation.
Knowing that extravasation alone is not sufficient for success-
ful metastatic growth in the liver as well as brain and that the
majority of the carcinoma cells undergo apoptosis afterward,
it makes the microglia-carcinoma cell interaction at this time
point even more interesting (Chambers et al., 2002; Kienast
et al., 2009). Reasons for the lack of reports on glial-carci-
noma interactions relate to the difficulty of distinguishing res-
ident microglia from invading bone marrow-derived
monocytes=macrophages using histology. It is also due to the
limited availability of patient samples, and the absence of
suitable mouse models to study the brain microenvironment
during cerebral colonization.
We therefore established an ex vivo coculture model,
which consists of an organotypic brain slice and a 3D-
carcinoma cell plug. This method allows not only the direct
visualization of carcinoma cell-microglia interactions without
any contamination of blood-derived macrophages but also
allows us to study and target microglia as well as other resi-
dent cells within the brain tissue. In direct contrast to the
expected tumor defense function, microglia in this coculture
model fostered malignant invasion of different breast cancer
cell lines (MCF-7 and 410.4) by serving either as guiding
structures or even as transporters for single invading carci-
noma cells as well as carcinoma cell cohorts (Pukrop et al.,
2010). Interestingly, gene expression studies of inflammatory
microglia in coculture with carcinoma cells identified TLR
and WNT signaling as the most affected pathways in micro-
glia. TLR signaling is by far the best described system for
DAMP actions, and WNT signaling controls very important
functions in tissue regeneration and repair. Moreover, WNT
pathways are essential for the communication between TAM
and carcinoma cells (Ojalvo et al., 2010; Pukrop et al., 2006)
as well as in the formation of brain metastasis (Bleckmann
et al., 2013; Klemm et al., 2011; Nguyen et al., 2009; Smid
et al., 2008).
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In addition, the C-X-C chemokine receptor 4
(CXCR4), recently described as a DAMP receptor for extrac-
ellular ubiquitin (Saini et al., 2010), was identified as the
most upregulated gene in microglia (Pukrop et al., 2010).
CXCR4 has been characterized in different cancer types as a
progression marker, its inhibition preventing metastasis for-
mation (Zlotnik et al., 2011). Its chemokine ligand stroma-
derived factor 1 (SDF1) has also been found to be massively
upregulated after various brain injuries, thus indicating a role
in benign brain damage responses (Bye et al., 2012).
In our current study, we employed our brain slice cocul-
ture system, a transgene zebrafish model as well as human
brain metastasis samples to further dissect molecular elements
and cellular mechanisms of the recently described unexpected
phenomenon of microglia-assisted invasion. Furthermore, our
aim was to determine (i) the specificity of this process for car-
cinoma cells, (ii) the potential involvement of cells other than
microglia, and (iii) the role of CXCR4 as well as (iv) to
investigate essential WNT signaling contributions during this
process in more detail.
Materials and Methods
Cell Lines and Primary Culture
The human breast cancer cell line MCF-7 and the Madin–Darby ca-
nine kidney cell line (MDCK) were purchased from DSMZ and
ATCC, respectively. They were maintained in RPMI-1640 medium
(PAA Laboratories, C€olbe, Germany) supplemented with 10% fetal
calf serum (FCS, Invitrogen, Karlsruhe, Germany). The human
mammary epithelial cell line (hTERT-HME1) was purchased from
BD Biosciences Clontech (Heidelberg, Germany) and was main-
tained in mammary epithelial cell medium (PromoCell, Heidelberg,
Germany). Cells were mycoplasma-free during regular controls. Sta-
ble transfections with the mammalian Turbo GFP vector (FP512,
Evrogen, Heidelberg, Germany) were performed with the Nanofectin
kit (PAA Laboratories, C€olbe, Germany) in accordance with the
manufacturer’s protocol and selection was performed through geneti-
cin resistance (G418, Roche, Basel, Switzerland). To obtain homoge-
neous GFP expression, cells were sorted using fluorescence-activated
cell sorting method (FACS, BD FACS Aria II, Heidelberg, Ger-
many). Primary microglia and astrocytes from newborn mice were
prepared as previously described (Regen et al., 2011). Cell viability
was measured by MTT conversion according to standard protocols.
Microinvasion Assay and Organotypic Brain Slice
Coculture System
The degree of invasion of MCF-7 and MDCK cells was measured
in coculture with astrocytes or microglia without direct cell-to-cell
contact using a modified Boyden chamber assay as described previ-
ously (Pukrop et al., 2010). 105 MCF-7 or MDCK cells and
23 105 of microglia or astrocytes were applied for 96 h. Mice of
the C57BL=6 or NMRI were decapitated between postnatal day 6
and 8 for the organotypic brain slice coculture experiments, which
were performed with the interface technique following the previously
described protocol (Kreutz et al., 2009; Pukrop et al., 2010). To
investigate the influence of different cortex regions, brain slices were
categorized into three levels according to the anatomical planes. As
means of orientation, we used the architecture of the cerebrum,
brain stem, and ventricles in the obtained slices. We obtained six
horizontal whole brain slices in general. The first two cranial slices
were defined as level one, the third and fourth were level two, and
both caudal slices as level three. These organotypic brain slices were
cocultured with 105 MCF-7 or MDCK cells, embedded in 85%
extracellular matrix (ECM gel; R&D Systems, Wiesbaden, Ger-
many). Recombinant Dickkopf 2 (DKK2, 200 ng=mL, R&D sys-
tems, Wiesbaden, Germany) and AMD3100 octahydrochloride
(AMD3100, also known as plerixafor, 1 mg=mL, Sigma, Munich,
Germany) were applied to inhibit the WNT and CXCR4 pathway,
respectively. The time-lapse imaging experiments were performed on
a Leica inverted DMI 6000B microscope with a 10-fold magnifica-
tion lens and a Leica DFC 350 FX CCD camera (Leica, Wetzlar,
Germany). As recently described, the live staining of microglia was
performed with 2 mg ILB4-Alexa Fluor 568 in advance. Images were
processed using the software Video Spin (http:==www.videospin.
com=Redesign=).
Histology and Immunohistochemistry of Brain Slices
and Human Tissues
Human tumor tissue samples were obtained from neurosurgically
resected brain metastases following approval of the local ethics com-
mittee. Immunohistochemistry was performed based on a modifica-
tion of a previously described protocol (Nessler et al., 2006). The
KiM1P staining was performed as previously described (Pukrop
et al., 2010). Human tissue and brain slice coculture sections for
immunohistochemistry were embedded in paraffin, cut into 2–5mm
sections with a microtome (Leica SM 2000R, Leica, Wetzlar, Ger-
many) and mounted on glass slides. The sections were de-waxed,
rehydrated, and stained with the following primary antibodies: poly-
clonal rabbit anti-CXCR4 protein (1:100, Abcam, Cambridge, UK),
monoclonal anti-KiM1P antibody (1:500, kindly provided by Prof.
H. J. Radzun, G€ottingen, Germany), and polyclonal rabbit anti-glial
fibrillary acidic protein (GFAP) (1:200, Dako, Glostrup, Denmark)
to detect astrocytes. Pretreatment with 10 mM citrate buffer (pH
6.0) in a microwave oven for 3 min was required in preparation for
GFAP staining. Antibody detection was achieved with biotinylated
anti-rabbit secondary antibody followed by avidin-peroxidase. Ami-
noethylcarbazole (AEC) was used as chromogen for CXCR4 stain-
ing. Control sections were incubated either in absence of primary
antibodies or with isotype controls or with nonimmune sera. After
counterstaining with hematoxylin, slides were covered with coverslips
and analyzed. To quantify the CXCR4 expression in human tissue,
we evaluated the slides with a microscope according to the following
scoring system: 05 none of the cells; 15 up to 5%; 115 5–10%;
and 1115>10% express CXCR4.
Immunofluorescence Staining of Astrocytes and
Microglia in the Organotypic Brain Slice Coculture
Immunofluorescence staining of microglia and counterstaining with
DAPI were completed as previously described (Pukrop et al., 2010).
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Astrocytes were detected by anti-GFAP (1:200, Sigma, Munich, Ger-
many). Organotypic cocultures were incubated with the primary
anti-GFAP antibody for 36 h at 4C, followed by anti-mouse-
TRITC staining for 1 h (1:100, Sigma, Munich, Germany). The
degree of invasion was evaluated using the recently described scoring
system from 0 to 111 (Pukrop et al., 2010). The degree of micro-
glia accumulation at the interface to the tumor plug was categorized
with following scoring system: 115<25%; 215 25–50%; 315
50–75%; and 41575% of the contact area with the cell plug of
the whole brain slice surface was positive for microglia. Double
staining of microglia and astrocytes was performed using anti-GFAP
and anti-mouse-TRITC antibodies as described above, followed by
ILB4-Alexa Fluor 647 (Invitrogen, Germany) and DAPI counter-
staining. Samples were mounted in DAKO fluorescent mounting
medium (Dako, Glostrup, Denmark), coverslipped, and analyzed
with a Zeiss confocal laser scanning microscope (LSM 510, Zeiss,
G€ottingen, Germany).
Live–Dead Staining
MCF-7 and MDCK cells were cocultured with brain slices for up to
96 h. To investigate the related mechanism, bisphosphonate clodro-
nate (100mg=mL, Roche, Basel, Switzerland), DKK2 (200 ng=mL),
and AMD3100 (1 mg=mL) were applied. Live and dead cells were
quantified using a Calcein-AM and propidium iodide (PI) double
staining kit according to the manufacturer’s protocol (AnaSpec, CA).
Calcein-AM and PI-positive cells were counted in three random
fields with the Image J software (Image J 1.43f). Results were
described as a percentage of the numbers of living cells to total cells
(live cells=live cells 1 dead cells). The UV-irradiated samples served
as positive control.
Reverse Transcription and Quantitative Real-Time
Polymerase Chain Reaction
Total RNA was isolated using the TRIzol Reagent (Invitrogen, Karls-
ruhe, Germany) including a DNase I digestion. cDNA synthesis and
PCR were performed as previously described (Klemm et al., 2011).
Whole brain slices were treated with clodronate (100 mg=mL) for
48 h. For primer sequences, please refer to Supporting Information
Table 1. Gene expression levels were normalized to the average of
the respective housekeeping (HK) genes and expressed as fold
changes (fc) followed by analyses with the comparative cycle thresh-
old (Ct) method as described (Pukrop et al., 2010).
Immunoblot (Western Blot) and
Immunofluorescence Staining for CXCR4
To assess protein expression and the distribution of CXCR4 on differ-
ent cells, we performed immune-blot (IB) and immunohistochemical
staining with the primary rabbit polyclonal CXCR4 antibody
(1:2,000, Abcam, Cambridge, UK). To prepare for IB, samples of
whole cell lysate from MCF-7, MDCK, primary microglia or astro-
cytes (40 lg each) were processed with 10% SDS-polyacrylamide gel
(PAGE) and visualized using enhanced chemoluminescence (ECL, GE
Healthcare, Pollards Wood, UK) with the Fuji LAS 4000 image sys-
tem. For the immunofluorescence, cells were incubated with the pri-
mary antibody for 1 h at RT (1:100, Abcam, Cambridge, UK),
followed by staining with anti-rabbit-TRITC for 1 h (1:100, Sigma,
Munich, Germany). They were then counterstained with DAPI, cover-
slipped, and analyzed with a confocal microscope as described above.
Analysis of Microarray Datasets
Three Affymetrix datasets containing 28 brain metastasis samples of
primary adenocarcinomas of the lung (GSE14108), 22 brain metasta-
ses from primary breast cancers (GSE14017, GSE14018), and 11
brain tissue samples of healthy controls (GSE5389) were retrieved
from the NCBI Gene Expression Omnibus (GEO) data repository
(Barrett and Edgar, 2006). All samples were combined into one dataset
and quantiles normalized. All analyses were performed using the free
statistical software R (version 2.15.1; http:==www.r-project.org).
Microglial Chemotaxis Assay
Microglia were seeded into inserts (3 mm pore size, BD Biosciences,
Heidelberg, Germany) at a density of 0.73 105=300 mL culture me-
dium and pretreated after 1 h with 1 mg=mL AMD3100 for 2 h.
Microglia-containing inserts were placed into 24-well dishes into
which either 0.73 105 MCF-7 cells or MDCK cells had been
seeded before and stained with 2 mM Calcein-AM (Sigma-Aldrich,
Munich, Germany). Nonmigrated cells were removed from the
upper side of the insert membrane by intense scraping, while
migrated microglia on the lower side were fixed with 4% PFA and
analyzed using fluorescence microscopy (Axio Observer D1, Carl
Zeiss, G€ottingen, Germany).
Transgenic Zebrafish Experiments
Fish were kept at 26.5C in a 14 h light=10 h dark cycle. Embryos
were collected by natural spawning and raised at 28.5C in E3-solu-
tion. To avoid pigmentation, 0.003% PTU was added 1 day postfer-
tilization (dpf). Embryos were staged according to Kimmel et al.
(1995). Microglia were visualized using the pu1:Gal4-UAS-GFP
transgenic line (Peri and Nusslein-Volhard, 2008). For live imaging
purposes, three dpf zebrafish larvae were anesthetized in 0.01% tri-
caine and embedded in 1.5% low melting point agarose. We used an
Olympus FV 1000 with a 40X=NA1.15 objective for the imaging. In
general, we captured 30–40 z-stacks spanning 45–60mM for full
brain recordings. Images were flattened by maximum projection in
Imaris (Bitplane) and Fiji software. Lesions were generated using a
pulsed 532 nm laser coupled to the FV 1000. Images were analyzed
using both Imaris (Bitplane) and Fiji software. The CXCR4 morpho-
lino oligonucleotide (50-AAATGATGCTATCGTAAAATTCCAT-30)
was obtained from Gene Tools. The morpholino was injected at a
concentration of 1 mM with 0.2% phenol red (Sigma) and 0.1 M
KCl (Sigma) into one-cell-stage zebrafish embryos.
Statistics
All data represent the mean6 standard error of the mean (SEM).
Differences were analyzed with either the Student’s t-test or the
Kruskal-Wallis test. To determine statistical significance at different
time points, we implemented one-way ANOVA. Correlation
between tumor invasion and microglial accumulation or the level of
brain slices was analyzed using a Spearman’s correlation test. P-values
1334 Volume 61, No. 8
 0.05 were considered statistically significant. In the figures * rep-
resents P< 0.05; **P< 0.01; and ***P< 0.001).
Results
Brain Slices from Different Cortex Regions
Demonstrate Comparable MCF-7 Cell Invasion
Since metastases occur in various regions of the brain, we first
analyzed whether the region, from which the organotypic
brain slice for our slice coculture was cut, had any influence
on the degree of tumor cell invasion. Therefore, we catego-
rized the cortex of the whole brain slices according to anat-
omy into three different cranial-caudal levels and performed
cocultures adjacent to the cerebral cortex in the vicinity of
the hippocampus (Supp. Info. Fig. 1A). There was no differ-
ence with regard to either the viability of the slice or the
invasion of MCF-7 cells (Supp. Info. Fig. 1B,C).
Astrocytes Are Part of the Glial Reaction
Previously, it was shown that astrocytes are part of the gliosis
reaction directly at the border with the metastatic tissue (Zhang
and Olsson, 1997). This led us to assume that astrocytes may be
involved in the host tissue response against the growing meta-
static and tissue destructing carcinoma cells. We compared the
astrocyte and microglia reaction in brain slice coculture system
by confocal investigations (Fig. 1) with human brain metastasis
samples using immunohistochemistry (IHC) (Fig. 2). The con-
focal investigations of the 350-mm-thick whole brain slices
revealed that astrocytes form direct contacts with the breast can-
cer cells at the interface with the 3D-plug and at the invasion
front. However, astrocytes are organized as a mesh in the 3D-
MCF-7 plug (Fig. 1A,B) and form a barrier in the brain tissue
(Fig. 1C), whereas microglia act more heterogeneously and with
the potential to leave the brain slice as individual cells and
FIGURE 1: Astrocytes and microglia are part of gliosis and interact with MCF-7 in the slice cocultures. (A–F) Double staining of the coculture with the
organotypic brain slice and MCF-7-GFP (green) in the 3D-tumor plug were applied for astrocytes (anti-GFAP-TRITC5 red) and microglia (ILB4-Alexa
Fluor 6475violet), except (A2) is only a single astrocytic staining for better illustration (A1 and A2) The astrocytes form a mesh in the tumor plug con-
tacting the MCF-7 cells with their protrusions. Interestingly, these astrocytes remain connected with other astrocytes and the brain tissue. (B) A lateral
part of the brain slice which is adjacent to the tumor plug. In contrast to astrocytes, microglia leave the brain slice as individual cells (A1, B). In the
brain tissue, both glial cells are activated at the invasion zone, especially the astrocytes attempt to form a dense barrier in the brain slice next to the
tumor plug (C1 and the contact area in higher magnification C2). (D–F) These examples illustrate frequently detectable interactions of astrocytes and
microglia with the same MCF-7 cells in the tumor plug. Scale bars represent 50 mm. [Color figure can be viewed in the online issue, which is available
at wileyonlinelibrary.com.]
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migrate into the 3D-plug. Microglia activation in particular is
locally restricted to the contact area (see Supp. Info. video 1).
Interestingly, both glial cells often contact and interact with the
carcinoma cells, sometimes also simultaneously (Fig. 1D–F).
Similar Morphology Observed in Human Brain
Metastasis Samples
The glial reaction in the human brain metastasis samples is very simi-
lar to the slice coculture system in Fig. 1. Microglia=macrophages
are also activated in the adjacent brain tissue and accumulate at the
interface. Moreover, the reaction of microglia=macrophages at the
interface as well as adjacent brain tissue is much severe when infiltrat-
ing carcinoma cells are present. This is demonstrated in Fig. 2A2,
with infiltrating breast carcinoma cohorts, in comparison to Fig.
2A3, with a sharp border between the metastatic and the adjacent
brain tissue. Moreover, in contrast to the astrocytes, the major-
ity of microglia=macrophages infiltrate into the metastatic tissue
(Fig. 2A1–3). The GFAP staining revealed the majority of the
activated astrocytes in the adjacent brain tissue. Furthermore,
they form a barrier at the interface to the metastatic tissue;
and only few cells enter the tumor mass (Fig. 2B1–3). How-
ever, at the interface we detected astrocyte protrusions in direct
contact with the carcinoma cells.
Microglia-Assisted Invasion Is Restricted to
Malignant Cells
Next, we inquired as to whether this gliosis reaction and
microglia-induced invasion in our coculture system represents
FIGURE 2: Distribution of microglia and astrocytes in human brain metastases. The reaction of the microglia and astrocytes in human brain
metastasis samples is comparable to the brain slice coculture system. (A1–A3) Macrophage=microglia staining was performed employing the
anti-KiM1P antibody. Activated macrophages=microglia accumulate in the adjacent brain tissue and at the interface. The majority of the acti-
vated macrophages=microglia infiltrate into the metastatic tissue. (B1–B3) Astrocyte response was demonstrated by GFAP IHC staining. Acti-
vated astrocytes accumulate in the adjacent brain tissue and form a barrier at the interface to the metastatic tissue. Furthermore,
comparable to the brain slice coculture system, only few cells enter the tumor mass. [Color figure can be viewed in the online issue, which
is available at wileyonlinelibrary.com.]
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a specific phenomenon of malignant cells or whether it occurs
in a nonselective manner. To this aim, we first measured the
degree of invasion of the benign epithelial cell line MDCK as
well as that of the malignant MCF-7 in a modified Boyden
chamber assay with and without indirect coculture with
microglia. In contrast to the carcinoma cells, the invasion of
MDCK was not enhanced by microglia (n  9; P< 0.001)
(Fig. 3A). Similarly, there was only minimal invasion of
MDCK in the organotypic whole brain slice coculture, when
compared with MCF-7 (P< 0.05) (Fig. 3B). Despite the
diverging effects on invasion, the extent and morphology of
the glial reaction did not differ between benign and malignant
cells (Figs. 1C and 3C; Supp. Info. video 2 (MCF-7 cocul-
ture) and video 3 (MDCK coculture)). Using time-lapse mi-
croscopy, microglia-epithelial cell interactions could be further
discriminated into at least three morphological subtypes in
both coculture systems (Fig. 3D,E). We observed microglia
reaching out from the brain slice with long protrusions (up to
120 mm) to contact individual epithelial cells as well as cell
cohorts, pulling them toward the brain slice (subtype A).
Microglia cells could also completely enter the 3D-cell plug.
The subtype B cells had an elongated shape with long protru-
sions, were very mobile, and formed short-term contacts with
both epithelial cell types. Subtype C cells were round and of-
ten attached to the surface of epithelial cells, sometimes acting
as transporters as previously described (Pukrop et al., 2010).
In some cases, we detected a rapid transition between the lat-
ter two subtypes, indicating that microglia could switch
between these phenotypes (see Supp. Info. video 4).
MDCK But Not MCF-7 Cells Undergo Apoptosis in
the Vicinity of the Brain Slice
To further investigate why only malignant cells invade the brain
although both cell types are contacted by glial cells in the same
way at Position 1 (interface, for scheme refer to Fig. 4A) we an-
alyzed MCF-7 and MDCK in the 3D-plug by live–dead stain-
ing after 96 h of coculture. At this point, we measured the
viability at Position 1, the area at which glial-epithelial cell
interactions take place, as well as in the opposite region (Posi-
tion 2), at which these interactions are absent (Fig. 4B and
Supp. Info. video 5). There was no significant difference in the
viability of MDCK or MCF-7 cells at Position 2. However, the
majority of the MDCK cells at Position 1 were positive for PI.
This was in direct contrast to both the situation noted at Posi-
tion 2 and to MCF-7 cells in general. To validate this distinc-
tion, we quantified the fluorescence signals in the double
staining for live (calcein-AM, green) and dead cells (PI, red)
using Image J software. We confirmed that only 22.3% (me-
dian) of the MDCK cells were still viable at Position 1, in com-
parison with 93.6% at Position 2 (Fig. 4C–E). Moreover, the
MDCK nuclei at Position 1 demonstrated the typical features
of apoptosis in contrast to Position 2 or to MCF-7 at both
positions (Fig. 4D,E inserts). In summary, in the area of contact
with the 3D-epithelial cell plug, the locally restricted glial reac-
tion occurred independently of the nature of the epithelial cell.
After the uniform contact phase, however, the glial reaction
induces apoptosis in the benign epithelial cells. This fails to
occur in carcinoma cells, with the added twist that the reaction
actually appears to foster invasion.
Microglia and WNT Are Involved in MDCK
Apoptosis
Next, we addressed the question as to whether microglia are
involved in MDCK apoptosis. We proceeded by depleting
microglia in the organotypic brain slice using the bisphospho-
nate clodronate, as recently described (Kreutz et al., 2009;
Pukrop et al., 2010). The microglial marker gene expression
of csf1r and f4=80 was significantly reduced in the entire brain
slices after 48 h as determined by qRT-PCR (Fig. 5A).
Although we already noted a slight but significant decrease in
MDCK cell viability upon application of clodronate
(100 mg=mL) in the control culture (Supp. Info. Fig. 2A), the
depletion of microglia led to a significant increase in the num-
ber of living MDCK cells at Positon 1 in our coculture system
(Fig. 5B,C). To test whether WNT-signaling, which is
involved in microglia-induced carcinoma invasion (Pukrop
et al., 2010), also regulates microglia-induced apoptosis, we
treated the MDCK-organotypic brain slice coculture with
DKK2. This led to an increase of MDCK viability at Position
1 similar to that obtained with microglia depletion (Fig. 5C).
Nevertheless, in contrast to microglia-induced MCF-7 inva-
sion, which is almost completely abolished by these inhibitors
(Pukrop et al., 2010), both treatments could only achieve a
partial rescue of apoptosis. This appears to indicate the
involvement of at least one additional cell type, such as astro-
cytes. More important, microglia as well as WNT signaling
seem to have more influence on transport and invasion of the
cacrinoma cells than to apoptosis of the begnin epithelial cells.
CXCR4 Is Involved in Microglia- and Astrocyte-
Induced Invasion
Considering the severe effects of microglia on malignant inva-
sion as well as the link of microglia activation and infiltrating
carcinoma cells (as demonstrated above Fig. 2A2–3), we
investigated the correlation between astrocytes=microglia
accumulation in the contact area and the degree of MCF-7
invasion in our coculture system. While the degree of astro-
cyte accumulation did not have any major influence, micro-
glia accumulation significantly correlated with MCF-7
invasion based on a series of 203 coculture experiments
(P< 0.001) (Fig. 6A). We further evaluate the candidate
genes which are possibly involved in microglia-induced by
qRT-PCR. Consistent with our previous microarray results on
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FIGURE 3: Comparison of the astrocytic and microglial reactions as well as their effects on benign and malignant epithelial cells. (A) Boy-
den chamber assays were performed with malignant MCF-7 or epithelial (benign) MDCK cells6 indirect microglia coculture. Data repre-
sent mean6SEM with n  9. (B) Cocultures with 3D-MCF-7-GFP or 3D-MDCK-GFP cells. Data represent the degree of MCF-7 or MDCK
invasion into the brain slice at the contact area after 96 h. (C) Double stainings of astrocytes (anti-GFAP-TRITC5 red) and microglia
(ILB4-Alexa Fluor 6475 violet) of the MDCK-GFP (green) coculture. The gliosis reaction of astrocytes and microglia was comparable to
the MCF-7 coculture (see Fig. 1D), however, MDCK did not invade the slice (scale bars represent 50 mm). (D and E) Excerpts of time-
lapse experiments illustrating three different microglial subtypes in MCF-7 and MDCK cocultures (T5MCF-7 cells; E5MDCK cells, white
arrows5protrusions). Subtype A: microglia resident in the brain slice with long protrusions into the 3D-plug (D1 and E1). Subtype B:
individual microglia in the plug forming short contacts (D2 and E2). Subtype C: round microglia directly attach to epithelial cell surface
over a long period (D3 and E3). This kind of microglia sometimes transports both epithelial cell types (scale bars represent 20 mm).
[Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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microglia cells (Pukrop et al., 2010), cxcr4 but not its ligand
cxcl12 (also known as stromal cell-derived factor-1, SDF1)
was upregulated in brain slices upon coculture (Fig. 6B,C).
We then scrutinized the protein expression of CXCR4 in
MDCK, MCF-7, microglia, and astrocyte. All cell types
expressed CXCR4 (Fig. 6D). Interestingly, both epithelial cell
types depicted rather homogeneous staining (Supp. Info. Fig.
3), whereas microglia and astrocyte revealed a heterogeneous
expression pattern (Fig. 6E). We then analyzed the influence
of murine astrocytes on carcinoma cell invasion in
comparison with microglia-induced invasion. Astrocyte cocul-
ture also induced carcinoma cell invasion in modified Boyden
chamber assays, however, to a much lower extent than micro-
glia (Fig. 6G). Additionally, both kinds of glia-induced cancer
cell invasion were significantly inhibited by the WNT-inhibi-
tor DKK2 as well as by AMD3100, a CXCR4 inhibitor (Fig.
6G) without cytotoxicity either to the epithelial cells, MCF-7
and MDCK, or the glia cells, microglia and astrocytes (Supp.
Info. Fig. 2B). Both inhibitors also reduced invasion of
MCF-7 into the whole brain slice to almost the same extent
(Fig. 6F). In contrast, the viability of MDCK at Position 1
was only slightly increased by the CXCR4 inhibitor, again
comparable to DKK2 treatment and microglia depletion (Fig.
6H). In conclusion, microglia have less influence on MDCK
apoptosis than on invasion of the carcinoma cells, for which
the effects of WNT or CXCR4 inhibition as well as microglia
depletion are more pronounced.
CXCR4 Expression in Astrocytes and Microglia in
Brain Metastasis Samples
Since we detected remarkable expression of cxcr4 in all of the
five investigated human cerebral metastases of breast and lung
carcinomas (Fig. 7A), we assessed the relevance of our qRT-
PCR results in external gene sets, one from normal brain
autopsies (GSE5389; n5 11), a second from breast
(GSE14017, GSE14018; n5 22), and the third from lung
adenocarcinoma brain metastasis (GSE14108; n5 28). As
expected, the normal brain samples revealed the lowest
expression, whereas cxcr4 expression in lung and breast metas-
tases demonstrated a wide range, including samples with very
high expression levels (Fig. 7B). Interestingly, the ligand
cxcl12 was not upregulated in comparison to normal brain
(Supp. Info. Fig. 4). Next, we analyzed the CXCR4 protein
FIGURE 4: Astrocyte and microglia interaction leads to MDCK apopto-
sis while MCF-7 survives. (A) Scheme of the experimental procedures:
the Position 1 (Pos 1) is directly adjacent to the brain slice; Position 2
(Pos 2) is at the contralateral side of the plug. (B) Representative phase
contrast images of coculture time-lapse experiments with live microglial
staining (red5 ILB4-Alexa Fluor 568). At Pos 1 (B1), microglia leave the
brain slice and distance themselves with a maximum of 600–800 mm
from the brain slice edge, thus microglia are absent at Pos 2 (B2) (scale
bars represent 200 mm). Inlays: the red rectangles illustrate the posi-
tions in the tumor plug (scale bars represent 1 mm). (C) Image J quanti-
fication: the box plots indicate the percentage of living cells compared
with total cells. Monocultured cell=tumor plugs served as positive con-
trols (CTL) and UV-irradiated cell=tumor plugs served as negative con-
trols (NC). At Pos 1 MDCK viability was reduced significantly, in
contrast MCF-7 cells demonstrated no significant change toward CTL
or both positions (data represent mean6SEM with n  9). (D and E)
Representative confocal images of the live (Calcein-AM5green) and
dead (PI5 red) staining of the epithelial cell=tumor plugs (scale bars
represent 100 mm), including the nuclei morphology (DAPI5blue, in
the insert, scale bars represent 10 mm) were shown. [Color figure can
be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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localization in normal brain tissue and cerebral metastases.
First, our histological findings confirmed the gene expression
pattern. While we detected no CXCR4 expression in normal
tissue at all, the metastasis samples demonstrated an expres-
sion ranging from absence to very high levels. Most impor-
tantly, in samples with evaluable adjacent brain tissue, we
discovered CXCR4 expression in the gliosis region next to
the metastatic tissue in 80% of breast and 68.8% of lung
cancer cerebral metastasis (Table 1; Fig. 7C–E).
CXCR4 Is Involved in Glial Response After Various
Types of Brain Injury
We then shifted our focus onto the influence of CXCR4 on
microglia recruitment and chemotaxis. Migration of microglia
toward MDCK and MCF-7 was significantly reduced by
AMD3100 (Fig. 8A,B), again independently of the epithelial
cell type. To clarify whether this is conferrable to other types
of cerebral damage response, microglia recruitment was meas-
ured in a brain injury assay in the microglia transgenic zebra-
fish line (pu1:Gal4-UAS-GFP). These transgenic zebrafish
allowed us to quantify in vivo the migration of individual
microglia cells toward the brain injury. In control animals,
56% of all microglia cells were recruited to the site of injury.
Following CXCR4-specific gene knock out by morpholino
treatment, this was reduced to 30.7% (median; P5 0.004)
(Fig. 8C). Interestingly, the effect was the more pronounced
the larger the distance was between microglia and injury, sup-
porting the hypothesis of a chemotactic gradient (Supp. Info.
video 6).
With regard to CXCR4 expression on the astrocytes in
culture and the human metastasis samples, we investigated
the morphological changes after AMD3100 and DKK2 treat-
ment in the brain slice coculture model. Both inhibitors had
a similar influence on the length of astrocytic protrusions
(Fig. 8D,E). Additionally, we performed CXCR4 IHC in
stroke patients in whom we discovered an upregulation of
CXCR4 in the glial cells and especially astroglial cells
(Fig. 8G).
Discussion
Our previous results demonstrated a comparable microglia
reaction and assisted invasion for the human breast cancer
cells MCF-7 as well as the murine breast cancer cell 410.4
(Pukrop et al., 2010). As a proof of principle of a benign epi-
thelial cell line, we chose the Madin-Darby Canine Kidney
(MDCK) cells in direct comparison with the malignant
MCF-7, originally derived from a metastatic patient. Other
immortalized epithelial cell lines, like the epithelial breast cells
hTERT, MCF-10A, and HMLE, were incompatible with the
brain slice conditions.
As illustrated by time-lapse and confocal microscopy in
the first phase, both glial cell types are activated and accumu-
late in the brain slice at the contact area with both epithelial
cell types. In the second phase, astrocytes construct a close-
knit meshwork directly at the interface, forming dense inter-
actions with the potential intruders and finally embedding
these in the meshwork. At the same time, microglial cells
demonstrate different modes of duties and interactions sup-
porting the recently emerging concept of responder subtypes
of microglia (Scheffel et al., 2012). Interestingly, some micro-
glia detach themselves from the brain slice rim and enter the
FIGURE 5: Microglia depletion and addition of DKK2 partially rescue MDCK apoptosis. (A) Clodronate (100 mg=mL) effectively reduced
the microglial markers csf1r and f4=80 in whole brain slices after 48 h of stimulation. Gene expression levels were normalized to the av-
erage of the respective housekeeping genes and expressed as fold changes (fc). Data represent mean6SEM with n  9 of three individ-
ual experiments. (B1 and B2) Representative confocal images of the live (Calcein-AM5green) and dead (PI5 red) staining of the
epithelial MDCK cells at Position 1. Microglia depletion leads to a partial rescue of MDCK viability after clodronate treatment (scale
bars represent 100 mm). (C) Image J quantification: Clodronate or DKK2 treatment resulted in a partial rescue of the glia-induced MDCK
apoptosis at Position 1. Data represent mean6SEM with n  9 of three individual experiments. [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
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FIGURE 6: CXCR4 and WNT signaling are involved in microglia- and astrocyte-induced invasion. (A) The degree of MCF-7 invasion and
microglia (MG) accumulation at the contact area=invasion front was determined in brain slice cocultures (n5203). The analysis revealed
a significant correlation between the degree of tumor invasion and the degree of microglial accumulation (Spearman’s test; P< 0.001).
(B and C) qRT-PCR results of cxcr4 and cxcl12 illustrated by the DCt method. Coculture with MDCK or MCF-7 cells for 96 h upregulates
cxcr4 but not its ligand, cxcl12 in the organotypic brain slices. Line represents the mean value of all experiments and each dot repre-
sents the mean value of triplicate analyses with n  15 from three individual experiments. (D) MDCK, MCF-7, microglia, and astrocytes
(AS) express CXCR4 protein detected by immunoblot. (E1 and E2) The glial cells astrocytes and microglia reveal a heterogeneous
expression pattern of CXCR4 (red) on immunofluorescence staining counterstained with DAPI (scale bars represent 20 mm). (F) The inva-
sion of the MCF-7-GFP cells into the whole brain slice was significantly reduced after DKK2 as well as AMD3100 treatment. (G) The influ-
ence of indirect cocultures with microglia or astrocytes on carcinoma cell invasion measured by modified Boyden chamber assays.
Treatment with WNT inhibitor DKK2 as well as CXCR4 inhibitor AMD3100 significantly reduced both the astrocyte- or microglia-induced
carcinoma cell invasion. Data represent mean6SEM with n  9 of three individual experiments. (H) The CXCR4 inhibitor also partially
rescued the glial-induced apoptosis of MDCK at Position 1 (scheme see Fig. 4A) similar to clodronate or DKK2 treatment shown in Fig.
5C. Data represent mean6SEM with n  9 from more than three individual experiments. [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
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FIGURE 7: CXCR4 expression in astrocytes and microglia in human brain metastasis samples. (A) qRT-PCR results of cxcr4 illustrated
by the DCt method. Human cerebral lung (L met) and breast cancer (B met) metastases samples demonstrate a marked expression of
CXCR4 in contrast to the benign epithelial cell line hTERT. Line represents the mean and each dot represents the mean value of triplicate
analyses with n  15. (B) Gene expression of cxcr4 is visualized using boxplots across all samples for the three different cxcr4 probes
(209201_x_at, 217028_at, 211919_s_at). Samples are ordered by means of cxcr4 gene expression. Black: normal brain tissues, red: cere-
bral breast metastases, and blue: cerebral lung metastases. (C–E) Expression and localization of CXCR4 were analyzed in normal brains,
cerebral metastasis of breast and lung cancer samples by immunohistochemistry. In normal brains, CXCR4 was undetectable (C), whereas
in cerebral metastases, CXCR4 expression was detectable in the metastatic cells, the metastatic stroma, and especially in astrocytes in
the gliosis region adjacent to the tumor cells (D and E) (scale bars represent 20 mm, in the left panel 200 mm). [Color figure can be viewed
in the online issue, which is available at wileyonlinelibrary.com.]
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tumor plug up to a distance of about 800 mm. Consequently,
interactions between epithelial cells and astrocytes as well as
microglia mainly take place at the interface of the reactive
brain tissue and the 3D-plug. Most importantly, the
morphology of the coculture system reflects the human situa-
tion demonstrated by our and previous histological findings
(Bos et al., 2009; Fitzgerald et al., 2008; Lorger and Felding-
Habermann, 2010; Pukrop et al., 2010; Zhang and Olsson,
1997). However, in the coculture system we are able to inves-
tigate the dynamics of the glia-carcinoma cell interaction,
including bright field time-lapse imaging.
Thus our results propose that epithelial cells foreign
to the brain are met by a general glial response of astro-
cytes as well as microglia. Importantly, this response is uni-
form in the first phase but with opposite outcome in the
second phase. Benign cells, such as MDCK, are effectively
killed by apoptosis, while the malignant MCF-7 or 410.4
are not eliminated. Not only do they survive this attack,
they actually misuse these interactions to their advantage to
foster their invasion.
Recently, it was additionally demonstrated that astro-
cytes could foster malignant cell proliferation and induce
chemotherapy resistance in tumor cells (Kim et al., 2011; Lin
et al., 2010; Seike et al., 2011). Here we demonstrate that
they may also enhance malignant invasion. Thus, astrocytes
and microglia activation could influence different characteris-
tics of malignant cells and could exacerbate cerebral metastasis
and not only the course of neurodegenerative diseases.
In contrast to these tumor-promoting functions, it is
also known that similar to our findings in the MDCK cocul-
ture, microglia together with astrocytes are capable of induc-
ing apoptosis at least in neurons (Bezzi et al., 2001). To what
extent astrocytes contribute to the apoptosis of MDCK in
our system needs further clarification. However, the coinci-
dence that carcinoma cells are met by activated astrocytes and
microglia directly after extravasation (Lorger and Felding-
Habermann, 2010) could be one explanation for the high
range of carcinoma cell apoptosis in this step of cerebral me-
tastasis (Chambers et al., 2002; Kienast et al., 2009).
Furthermore, it is generally accepted that circulating car-
cinoma cells disseminate to distant organs early in the often
long-lasting process of successful metastasis. Avoiding destruc-
tion of carcinoma cells during the first steps of metastasis in
the primary tumor or as circulating carcinoma cells by the
immune system is one of the recently added hallmarks of can-
cer (Hanahan and Weinberg, 2011). Considering that micro-
glia together with astrocytes have the capacity to induce
apoptosis of epithelial cells, we assume that resistance to the
organ-specific responses against the intruders could be an
additional important characteristic in the final steps of metas-
tasis, the colonization. Early reports of liver metastasis sup-
port this theory (Gjoen et al., 1989; Heuff et al., 1995), in
which the Kupffer cells were able to kill colon carcinoma cells
effectively. Thus, the resistance to organ-specific responses
directed toward the intruding epithelial cells could prove to
be the decisive function for successful colonization by cancer
cells.
At least two candidate pathways obviously play a role in
this setting. We recently identified WNT as a key regulator of
microglia-induced invasion (Pukrop et al., 2010). Here we
not only confirm this finding, we also reveal that the
enhanced invasion by astrocytes is also responsive to the inhi-
bition of WNT signaling by DKK2. Altogether, these findings
underline the role of WNT signaling during cerebral coloniza-
tion (Bleckmann et al., 2013; Klemm et al., 2011; Nguyen
et al., 2009; Pukrop et al., 2010; Smid et al., 2008).
Additionally, we demonstrate that the chemokine recep-
tor CXCR4 is involved in astrocyte as well as microglia
response in the coculture with the epithelial cells. It regulates
the migration of the microglia and at least the length of the
astrocyte protrusions. Most importantly, inhibition by
AMD3100 reduces the glia-assisted invasion in all coculture
settings. However, the analysis of the gene arrays and qRT-
PCR demonstrates no upregulation of SDF1 in brain metas-
tasis, whereas the receptor itself is. Metastatic growth causes a
lot of cell and tissue damage, which leads to the release of
ubiquitin to the extracellular space; thus ubiquitin could lead
to the activation of the corresponding DAMP receptor
TABLE 1: CXCR4 Expression in Cerebral Brain Metastasis of Breast Cancer and Lung Cancer Samples
Tissue Total CXCR4 expression in the carcinoma cells Total CXCR4 expression in the adjacent gliosis
type amount 0 1 11 111 amount 0 1 11 111
Breast cancer 23 3 (13.0%) 12 (52.2%) 6 (26.1%) 2 (8.7%) 15 3 (20.0%) 7 (46.7%) 4 (26.7%) 1 (6.6%)
Lung cancer 22 5 (22.7%) 13 (59.1%) 4 (18.2%) 0 (0%) 16 5 (31.2%) 8 (50%) 3 (18.8%) 0 (0%)
Human patient samples stained for CXCR4 with IHC in normal brain, lung, and breast cerebral metastasis samples. The metastasis samples
were analyzed for CXCR4 expression in the carcinoma cells as well as in the gliosis zone if available.
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CXCR4. That CXCR4 can act in damage response of micro-
glia is illustrated by the zebrafish experiments and by the
expression of CXCR4 in stroke patients as demonstrated here
and by others (Salmaggi et al., 2009; Wang et al., 2012). Fur-
thermore, CXCR4 signaling in microglia and astrocytes has
been observed in the context of HIV-induced neuronal apo-
ptosis and subsequent dementia (Bezzi et al., 2001). Interest-
ingly, we were also able to reduce partially the glia-induced
apoptosis of MDCK by AMD3100. Finally, it should be
noted that CXCR4 has physical—and most likely also func-
tional—association with TLR4, the latter complex being
more and more accepted for DAMP recognition (Triantafilou
et al., 2008). Thus, all these findings underline the role of
CXCR4 in brain tissue damage response in both physiologic
as well as pathologic situations, including cerebral metastasis.
However, CXCR4 and WNT signaling are involved pre-
dominantly in malignant progression but not so much in
glia-induced apoptosis of benign epithelial cells. This indi-
cates that these pathways are not the key players in glia-medi-
ated cell killing. Obvious candidates like NO or TNFa for
this effect will be tested in the MDCK coculture with inhibi-
tors or neutralizing antibodies.
Taken together, the activation of at least one well-estab-
lished pathway for repair and regeneration (WNT) and addi-
tionally the recently defined DAMP receptor CXCR4 links
this glial activation to a damage response. This is further sup-
ported by the finding that the best-studied DAMP signaling
system (TLR) was also under the most affected pathways in
our previous screening in microglia. Moreover, the glial reac-
tion and its signaling seems transferable to other injury
FIGURE 8: CXCR4 knockdown= inhibition affects microglial and astrocytic damage response. (A and B) Results of the microglia chemo-
taxis assays toward MDCK and MCF-7 cells. Both cocultures significantly enhanced microglia migration. (A) Representative microglial
images were shown6MDCK coculture and6 treatment with the CXCR4 inhibitor (AMD 3100, 1 mg=mL). AMD3100 reduced the enhanced
microglial migration toward MDCK almost to CTL level (scale bars represent 200 mm). (B) Results demonstrate migrated microglial cells per
103 field, data represent mean6SEM; n540. (C) Knockdown effects of CXCR4 in zebrafish larvae: Percentage of microglia in the optic tec-
tum moving to the injury site in CTL (n512) and CXCR4-morpholino (CXCR4-Mo) injected embryos (n511) were measured. The CXCR4-Mo
significantly reduced the microglial migration toward the injury site (line5mean and SEM, P50.004). (D and E) Cocultured with 3D-MCF-7-
GFP for 96 h61 mg=mL of AMD3100 were stained with anti-GFAP-TRITC (red). The length of the astrocyte protrusions were reduced after
AMD3100 (P< 0.001) or DKK2 (P50.009) treatment (scale bars represent 100 mm); line5mean and SEM (n  15). (F) Protein expression of
CXCR4 in human stroke samples using IHC (scale bar represents 20 mm, in the upper panel 200 mm). [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
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models and diseases of the brain tissue. Thus, epithelial cells
foreign to the brain induce a kind of damage response and
induce the assembly of astrocytes and microglia at the inter-
face, which is the prerequisite for the subsequent step of cell
killing. In the case of malignant cells, however, this initial
phase of damage-induced liaison is not followed by the phase
of effective apoptosis, providing the malignant cells with the
opportunity to exploit the glial contact to enhance their inva-
sion. Although the exact mechanism as to how malignant
cells escape apoptosis is unclear, both phases are obviously de-
pendent on WNT and CXCR4 signaling, however with more
effects on malignant progression than on glia-mediated
apoptosis.
Finally, the manipulation of the organ-specific damage
response may prove to be an innovative therapeutic strategy
in the treatment or even prevention of cerebral metastasis.
However, we have to consider that other host organs differ in
their damage response. Therefore, we will really need to
understand fully the damage systems and their responses in
all affected organs after the processes of dissemination, during
seeding, and growth of micro- as well as macrometastasis in
the future.
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